369 related articles for article (PubMed ID: 36091042)
21. Endothelial Zeb2 preserves the hepatic angioarchitecture and protects against liver fibrosis.
de Haan W; Dheedene W; Apelt K; Décombas-Deschamps S; Vinckier S; Verhulst S; Conidi A; Deffieux T; Staring MW; Vandervoort P; Caluwé E; Lox M; Mannaerts I; Takagi T; Jaekers J; Berx G; Haigh J; Topal B; Zwijsen A; Higashi Y; van Grunsven LA; van IJcken WFJ; Mulugeta E; Tanter M; Lebrin FPG; Huylebroeck D; Luttun A
Cardiovasc Res; 2022 Mar; 118(5):1262-1275. PubMed ID: 33909875
[TBL] [Abstract][Full Text] [Related]
22. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
[TBL] [Abstract][Full Text] [Related]
23. Glycogen synthase kinase 3 activity enhances liver inflammation in MASH.
Khoury M; Guo Q; Furuta K; Correia C; Meroueh C; Kim Lee HS; Warasnhe K; Valenzuela-Pérez L; Mazar AP; Kim I; Noh YK; Holmes H; Romero MF; Sussman CR; Pavelko KD; Islam S; Bamidele AO; Hirsova P; Li H; Ibrahim SH
JHEP Rep; 2024 Jun; 6(6):101073. PubMed ID: 38882600
[TBL] [Abstract][Full Text] [Related]
24. New aspects of hepatic endothelial cells in physiology and nonalcoholic fatty liver disease.
Sun X; Harris EN
Am J Physiol Cell Physiol; 2020 Jun; 318(6):C1200-C1213. PubMed ID: 32374676
[TBL] [Abstract][Full Text] [Related]
25. Single-Cell Transcriptomics Reveals Zone-Specific Alterations of Liver Sinusoidal Endothelial Cells in Cirrhosis.
Su T; Yang Y; Lai S; Jeong J; Jung Y; McConnell M; Utsumi T; Iwakiri Y
Cell Mol Gastroenterol Hepatol; 2021; 11(4):1139-1161. PubMed ID: 33340713
[TBL] [Abstract][Full Text] [Related]
26. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.
Coombes JD; Choi SS; Swiderska-Syn M; Manka P; Reid DT; Palma E; Briones-Orta MA; Xie G; Younis R; Kitamura N; Della Peruta M; Bitencourt S; Dollé L; Oo YH; Mi Z; Kuo PC; Williams R; Chokshi S; Canbay A; Claridge LC; Eksteen B; Diehl AM; Syn WK
Biochim Biophys Acta; 2016 Jan; 1862(1):135-44. PubMed ID: 26529285
[TBL] [Abstract][Full Text] [Related]
27. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
[TBL] [Abstract][Full Text] [Related]
28. The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
Bae CR; Zhang H; Kwon YG
PLoS One; 2020; 15(12):e0243497. PubMed ID: 33275637
[TBL] [Abstract][Full Text] [Related]
29. Restoration of Sinusoid Fenestrae Followed by Targeted Nanoassembly Delivery of an Anti-Fibrotic Agent Improves Treatment Efficacy in Liver Fibrosis.
Li F; Zhao Y; Cheng Z; Wang Y; Yue Y; Cheng X; Sun J; Atabakhshi-Kashi M; Yao J; Dou J; Yu J; Zhang X; Qi Y; Li X; Qi X; Nie G
Adv Mater; 2023 Apr; 35(17):e2212206. PubMed ID: 36862807
[TBL] [Abstract][Full Text] [Related]
30. Sinusoidal endotheliopathy in nonalcoholic steatohepatitis: therapeutic implications.
Ibrahim SH
Am J Physiol Gastrointest Liver Physiol; 2021 Jul; 321(1):G67-G74. PubMed ID: 34037463
[TBL] [Abstract][Full Text] [Related]
31. Immunonano-Lipocarrier-Mediated Liver Sinusoidal Endothelial Cell-Specific RUNX1 Inhibition Impedes Immune Cell Infiltration and Hepatic Inflammation in Murine Model of NASH.
Tripathi DM; Rohilla S; Kaur I; Siddiqui H; Rawal P; Juneja P; Kumar V; Kumari A; Naidu VGM; Ramakrishna S; Banerjee S; Puria R; Sarin SK; Kaur S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445195
[TBL] [Abstract][Full Text] [Related]
32. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
[TBL] [Abstract][Full Text] [Related]
33. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus core protein induces dysfunction of liver sinusoidal endothelial cell by down-regulation of silent information regulator 1.
Sun LJ; Yu JW; Shi YG; Zhang XY; Shu MN; Chen MY
J Med Virol; 2018 May; 90(5):926-935. PubMed ID: 29350417
[TBL] [Abstract][Full Text] [Related]
35. Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal Endothelial Cell Fenestration and Protecting Against Hepatic Fibrosis.
Desroches-Castan A; Tillet E; Ricard N; Ouarné M; Mallet C; Belmudes L; Couté Y; Boillot O; Scoazec JY; Bailly S; Feige JJ
Hepatology; 2019 Oct; 70(4):1392-1408. PubMed ID: 30964206
[TBL] [Abstract][Full Text] [Related]
36. Single-cell transcriptome reveals a novel mechanism of C-Kit
Li HY; Gao YX; Wu JC; Li JZ; Fu SW; Xu MY
Cell Biosci; 2024 Mar; 14(1):31. PubMed ID: 38461242
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice.
Chung KJ; Legaki AI; Papadopoulos G; Gercken B; Gebler J; Schwabe RF; Chavakis T; Chatzigeorgiou A
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902241
[TBL] [Abstract][Full Text] [Related]
38. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease.
Hammoutene A; Rautou PE
J Hepatol; 2019 Jun; 70(6):1278-1291. PubMed ID: 30797053
[TBL] [Abstract][Full Text] [Related]
39. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
[TBL] [Abstract][Full Text] [Related]
40. Endothelial TAZ inhibits capillarization of liver sinusoidal endothelium and damage-induced liver fibrosis
Hwang JH; Heo W; Park JI; Kim KM; Oh HT; Yoo GD; Park J; Shin S; Do Y; Jeong MG; Hwang ES; Hong JH
Theranostics; 2023; 13(12):4182-4196. PubMed ID: 37554269
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
